Concepedia

I. Foley

IF

Statistics

Publications

2

Citations

27

H-Index

2

Active since

2007

Affiliations

Novartis (Switzerland)(Current)

I. Foley is an author at Novartis (Switzerland) specializing in cost-effectiveness analysis, cost-effectiveness comparison, and cost-utility analysis.

Publications per year

2007–2010

2

Publications

2

Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom

Marc Botteman, M. Meijboom, I. Foley et al. · The European Journal of Health Economics · 2010 · 16 citations · Full text

, , +17

Economic value of zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer: The case of the United Kingdom (UK)

Marc Botteman, I. Foley, Aditya Marfatia et al. · Journal of Clinical Oncology · 2007 · 11 citations

, , +17

1–2 of 2